Search for: "McNeil v. CIR"
Results 1 - 20
of 191
Sort by Relevance
|
Sort by Date
23 Dec 2023, 7:16 pm
“Know then thyself, presume not God to scan; The proper study of Mankind is Man. [read post]
10 Feb 2023, 4:44 am
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
27 Dec 2022, 3:08 pm
Dist. v. [read post]
12 Sep 2022, 1:12 pm
” McNeil v. [read post]
29 Jun 2022, 11:28 am
WhenU (2d Cir. 2005). [read post]
12 May 2022, 6:45 am
Holdings, Inc., 696 F.3d 206 (2d Cir. 2012). [2] Gibson Guitar Corp. v. [read post]
21 Mar 2022, 6:53 am
For example, in the McNeil v. [read post]
17 Aug 2021, 9:08 am
McNeil Consultants, LLC, 2021 WL 3508713 (5th Cir. [read post]
14 Jun 2021, 10:31 am
Federal Trade Commission, 2021 WL 2385274 (2d Cir. [read post]
25 Oct 2017, 2:33 pm
Ins. v. [read post]
25 Oct 2017, 2:33 pm
Ins. v. [read post]
25 Oct 2017, 2:33 pm
Ins. v. [read post]
14 Sep 2017, 6:41 am
McNeil, 397 F. [read post]
17 Jul 2017, 9:41 am
Cir. 2012);see also Bristol-Myers Squibb Co. v. [read post]
30 Dec 2016, 12:15 pm
Pfizer Inc. v. [read post]
6 May 2016, 12:30 pm
McNeil Consumer & Specialty Pharm., 682 F. [read post]
22 Apr 2016, 12:51 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. 3d 281 (6th Cir. 2015); In re Celexa & Lexapro Marketing & Sales Practices Litigation, 779 F.3d 34 (1st Cir. 2015).Now there are three, and the latest is the most a fortiori of the lot.The Third Circuit has applied the Mensing/Bartlettimpossibility preemption rationale outside of the FDCA altogether, to preemption of design defect claims involving airplanes. [read post]
31 Mar 2016, 3:00 am
Ortho-McNeil Pharm., Inc., 808 F.3d 281 (6th Cir 2015). [read post]
3 Mar 2016, 5:19 am
See Larkin v. [read post]
18 Jan 2016, 5:00 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F.3d 281 (6th Cir. 2015) – preemption, but not involving generic drugs − which aptly described pre-approval theories as “never-start selling” claims (id. at 300), describes that other decision. [read post]
